Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Methylprednisolone in active ankylosing spondylitis
NCT01790022Phase 2Unknown
- Sponsor
- Saratov State Medical University
- Start
- Jul 2012
- Primary completion
- Mar 2013
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 2 trial of methylprednisolone in ankylosing spondylitis (AS), sponsored by Saratov State Medical University. Status: unknown.
02
Drugs
methylprednisolone
03
Conditions
ankylosing spondylitis (AS)
Beyond the preview
Go deeper on NCT01790022.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01790022.